Consistent with the results of preclinical study, the contents of IL-1ra, IL-6, IL-8, CXCL10, MCP-1, and IFN-γ in serum of the response MM and lymphoma patients were increased after one week of PM treatment (Fig. 6e). This evidence concerns the gene CXCL10 and Miyoshi myopathy.